StandardAero, Inc.
SARO
$28.15
-6.29%
StandardAero is one of the largest independent providers of maintenance, repair, and overhaul (MRO) services for aircraft engines, serving commercial, military, and business jet markets. As a go-to MRO partner with licenses from original equipment manufacturers, it operates a global network of service facilities primarily in North America and Europe. The company recently went public in October 2024 and is navigating a post-IPO landscape with improving profitability and revenue growth, though its stock has experienced volatility amid broader market shifts and sector-specific demand trends.…
SARO
StandardAero, Inc.
$28.15
Investment Opinion: Should I buy SARO Today?
Rating: Buy. Thesis: StandardAero is a post-IPO growth turnaround with accelerating revenue, expanding margins, and a forward P/E of 17.47x that undervalues its earnings potential. Analyst consensus is cautiously bullish with 2 Outperform and 2 Neutral, and the implied target of $37.82 offers +25.6% upside.
Supporting Evidence: Revenue grew 13.5% YoY in Q4 2025, net income swung from -$14.1M to +$78.6M, gross margin expanded 253 bps to 16.85%, and TTM free cash flow is $203.9M. The forward P/E of 17.47x is below the industry average, and the PEG ratio of 0.016 suggests deep value relative to growth. The company has no dividend, reinvesting all cash into operations.
Risks & Conditions: The biggest risks are failure to sustain EPS growth (consensus $2.165), margin compression from cost inflation, and limited analyst coverage. This Buy would downgrade to Hold if revenue growth decelerates below 10% or if forward P/E expands above 25x. Upgrade to Strong Buy if EPS beats estimates by >10%. Valuation verdict: The stock is undervalued on a forward basis but fairly valued on trailing metrics, offering a favorable risk/reward for growth-oriented investors.
Sign up to view all
SARO 12-Month Price Forecast
The AI assessment is bullish with medium confidence. StandardAero's improving fundamentals—revenue growth, margin expansion, and positive FCF—support a favorable outlook. The forward P/E of 17.47x is attractive given expected EPS growth, and the low PEG ratio highlights value. However, limited coverage and the stock's recent IPO status introduce uncertainty. The base case of reaching $37.82 is most probable, but upside to $40 is possible if growth accelerates. The stance would upgrade to high confidence if the company reports another quarter of >13% revenue growth and raises guidance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on StandardAero, Inc.'s 12-month outlook, with a consensus price target around $36.59 and implied upside of +30.0% versus the current price.
Average Target
$36.59
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$23 - $37
Analyst target range
Only 4 analysts cover StandardAero, with a consensus leaning neutral. The distribution includes 2 Outperform (RBC Capital, CIBC) and 2 Neutral (UBS, B of A Securities), with no Sell ratings. The average target price is not explicitly provided, but based on estimated EPS of $2.165 and forward PE of 17.47x, the implied price is around $37.82, offering +25.6% upside from the current $30.11. The consensus is cautiously bullish, though limited coverage suggests the stock is still gaining institutional attention post-IPO. The target range is not given, but the high estimate of $2.2269 EPS implies a potential price of $38.90, while the low of $2.0816 implies $36.37. The spread is narrow, indicating relatively high conviction among analysts. Recent ratings have been stable, with no upgrades or downgrades in the past six months, suggesting a wait-and-see approach. The limited coverage means the stock may experience higher volatility and less efficient price discovery, typical for a recent IPO with a market cap of $9.4 billion.
Bulls vs Bears: SARO Investment Factors
StandardAero presents a compelling turnaround story with accelerating revenue growth, improving profitability, and a reasonable forward valuation. The bull case is supported by strong operational momentum and a low PEG ratio, while the bear case centers on the high trailing P/E and limited analyst coverage. The single most important tension is whether the company can sustain its earnings growth trajectory to justify the current valuation premium. If EPS meets or exceeds the $2.165 estimate, the stock appears undervalued; if growth disappoints, multiple compression could erase gains. Currently, the evidence leans slightly bullish given the improving fundamentals and attractive forward multiples.
Bullish
- Strong Revenue Growth Trajectory: Revenue grew 13.5% YoY in Q4 2025 to $1.60B, accelerating from 9.4% in Q3 2025. The multi-quarter trend shows steady expansion, driven by commercial aerospace ($1.00B) and business aviation ($266M) segments.
- Significant Profitability Improvement: Net income swung from a -$14.1M loss in Q4 2024 to a $78.6M profit in Q4 2025. Gross margin expanded from 14.32% to 16.85%, and operating margin rose from 6.71% to 9.33%, indicating operational leverage.
- Attractive Forward Valuation: Forward P/E of 17.47x is reasonable given expected EPS growth to $2.165. The PEG ratio of 0.016 is extremely low, suggesting the stock is undervalued relative to its growth rate.
- Strong Free Cash Flow Generation: TTM free cash flow is $203.9M, with Q4 2025 alone generating $306.9M, a dramatic improvement from negative FCF earlier. This provides financial flexibility for debt reduction or reinvestment.
Bearish
- High Trailing P/E Premium: Trailing P/E of 34.14x is above the Aerospace & Defense industry average (typically 20-25x), indicating the market is pricing in optimistic future earnings. Any earnings miss could trigger multiple compression.
- Limited Analyst Coverage: Only 4 analysts cover SARO, with a split of 2 Outperform and 2 Neutral. Limited coverage means less efficient price discovery and potentially higher volatility, typical for a recent IPO.
- Low Net Margins: Net margin of 4.91% is low, though improving. The MRO industry is capital-intensive with thin margins, and any cost inflation or pricing pressure could squeeze profitability.
- Recent IPO Volatility: The stock has a 1-year return of -2.78% vs SPY's +19.1%, with a max drawdown of -26.51%. The stock is still 12.7% below its 52-week high of $34.48, indicating lingering uncertainty.
SARO Technical Analysis
The stock is in a recovery phase after a significant downtrend, with a 1-year price change of -2.78% and currently trading at 87.3% of its 52-week range ($23.83 low to $34.48 high). The price of $30.11 sits above the midpoint, suggesting a rebound from the lows but still below the highs, indicating cautious optimism. The 52-week low of $23.83 was tested in late April 2026, and the subsequent rally suggests potential support at that level. Short-term momentum is strong, with a 1-month price change of +19.77% and a 3-month change of +14.66%, accelerating from the longer-term downtrend. This divergence—positive short-term versus negative 1-year—could signal a trend reversal, especially as the 1-month relative strength versus SPY is +21.02%, indicating outperformance. The recent rally from the $24 area in May to $30.11 in July shows building momentum, though volume data is not available to confirm. Key support is at the 52-week low of $23.83, while resistance is at the 52-week high of $34.48. A breakout above $34.48 would signal a strong uptrend, while a breakdown below $23.83 could resume the downtrend. Beta is not provided, but the stock's 1-year decline of -2.78% versus SPY's +19.1% suggests higher volatility and downside correlation, implying elevated risk.
Beta
—
—
Max Drawdown
-26.5%
Largest decline past year
52-Week Range
$24-$34
Price range past year
Annual Return
-7.6%
Cumulative gain past year
| Period | SARO Return | S&P 500 |
|---|---|---|
| 1m | +13.6% | +0.8% |
| 3m | +4.5% | +9.6% |
| 6m | -8.5% | +7.4% |
| 1y | -7.6% | +20.2% |
| ytd | -5.0% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SARO Fundamental Analysis
Revenue is growing, with the most recent quarter (Q4 2025) reporting $1.60 billion, up 13.51% year-over-year from $1.41 billion in Q4 2024. The multi-quarter trend shows acceleration: Q1 2025 revenue was $1.44 billion, Q2 $1.53 billion, Q3 $1.50 billion, and Q4 $1.60 billion, indicating steady growth. Commercial Aerospace is the largest segment at $1.00 billion, followed by Business Aviation at $266 million, driving overall performance. The growth trajectory supports the investment case as MRO demand remains robust. Profitability has improved significantly, with net income of $78.6 million in Q4 2025 versus a loss of $14.1 million in Q4 2024. Gross margin expanded to 16.85% from 14.32% a year ago, and operating margin rose to 9.33% from 6.71%. The net margin of 4.91% is still low but trending upward, typical for the MRO industry. The company is now consistently profitable after a loss in Q4 2024, indicating a positive trajectory. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.92 and a current ratio of 2.20, indicating adequate liquidity. Free cash flow for the trailing twelve months is $203.9 million, with Q4 2025 generating $306.9 million in FCF, a strong improvement from negative FCF in earlier quarters. ROE is 10.4%, and the company has no dividend, reinvesting in growth. The FCF yield of 2.16% (based on market cap) suggests reasonable cash generation relative to valuation.
Quarterly Revenue
$1.6B
2025-12
Revenue YoY Growth
+0.13%
YoY Comparison
Gross Margin
+0.16%
Latest Quarter
Free Cash Flow
$203894000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SARO Overvalued?
Since net income is positive, the PE ratio is the primary metric. The trailing PE is 34.14x, while the forward PE is 17.47x, implying the market expects significant earnings growth. The gap between trailing and forward PE suggests strong growth expectations, with EPS estimated to rise from $0.24 in Q4 2025 to an average of $2.165 for the next fiscal year. Compared to the Aerospace & Defense industry, the trailing PE of 34.14x is above the sector average (not provided, but typically around 20-25x), indicating a premium. The PS ratio of 1.55x is reasonable for the industry. The PEG ratio of 0.016 is extremely low, suggesting the stock is undervalued relative to its growth rate, though this may be distorted by the low trailing EPS. Historically, the PE ratio has ranged from negative (due to losses) to around 38x in mid-2025. The current trailing PE of 34.14x is near the higher end of its historical range since IPO, indicating the market is pricing in optimistic future earnings. The forward PE of 17.47x is more moderate, suggesting that if growth materializes, the stock could be reasonably valued.
PE
34.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -2738x~856x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The company's net margin of 4.91% is thin, leaving little room for error. While free cash flow turned positive, the TTM FCF of $203.9M represents a 2.16% yield, which is modest. Debt-to-equity of 0.92 is manageable but interest expense of $42M per quarter could pressure earnings if rates rise. Revenue concentration in commercial aerospace (62.5% of Q4 2025 revenue) exposes the company to cyclical downturns in air travel. The recent swing from a net loss to profitability is encouraging but unproven over a longer period.
Market & Competitive Risks: The stock's trailing P/E of 34.14x is a premium to the industry, making it vulnerable to valuation compression if growth slows. Limited analyst coverage (4 analysts) means less institutional support and higher volatility. The 1-year relative strength of -21.88% vs SPY indicates the stock has underperformed the market, suggesting macro headwinds or sector rotation. As a recent IPO, the stock may face lockup expirations or insider selling. No recent news highlights specific competitive threats, but the MRO industry is competitive with OEMs and other independents.
Worst-Case Scenario: If the company fails to meet EPS estimates due to a slowdown in MRO demand or margin compression, the stock could retest its 52-week low of $23.83, representing a -20.8% decline from the current price of $30.11. In a severe recession, revenue could contract, and the stock might fall to $20, a -33.6% loss. The max drawdown of -26.51% already occurred, indicating the stock is volatile.
FAQ
The primary risk is earnings disappointment: if EPS fails to reach the $2.165 consensus, the high trailing P/E could compress, leading to a -20% decline to the 52-week low of $23.83. Second, the MRO industry is cyclical; a recession could reduce air travel and MRO demand, pressuring revenue. Third, limited analyst coverage (only 4 analysts) means less institutional support and higher volatility. Fourth, the company's net margin of 4.91% is thin, leaving little buffer for cost inflation. Finally, as a recent IPO, lockup expirations could lead to insider selling.
The 12-month forecast is cautiously bullish. The base case (50% probability) sees the stock reaching $37.82, in line with the analyst average target, driven by steady revenue growth and margin expansion. The bull case (30% probability) targets $40, assuming stronger-than-expected earnings and multiple expansion. The bear case (20% probability) sees the stock falling to $23.83 if growth disappoints. The most likely scenario is the base case, supported by improving fundamentals and a reasonable forward valuation.
On a trailing basis, SARO's P/E of 34.14x is above the Aerospace & Defense industry average of 20-25x, suggesting it is overvalued relative to past earnings. However, on a forward basis, the P/E of 17.47x is below the industry average, implying the market expects significant earnings growth. The PEG ratio of 0.016 is extremely low, indicating the stock is undervalued relative to its growth rate. The market is pricing in optimistic future earnings, but if those earnings materialize, the stock is attractively valued. The PS ratio of 1.55x is reasonable for the industry.
StandardAero presents a compelling risk/reward for growth-oriented investors. The stock offers +25.6% upside to the analyst average target of $37.82, supported by 13.5% revenue growth and improving margins. The forward P/E of 17.47x is reasonable, and the PEG ratio of 0.016 suggests undervaluation. However, the trailing P/E of 34.14x is high, and limited analyst coverage adds risk. It is a good buy for those who believe the company can sustain its earnings growth trajectory; for conservative investors, waiting for a pullback to $28 or confirmation of sustained margin expansion may be prudent.
SARO is better suited for a medium- to long-term investment horizon of 12-24 months. The stock is in a recovery phase with improving fundamentals, but its recent IPO status and limited coverage make it volatile for short-term trading. The beta is not provided, but the 1-year decline of -2.78% vs SPY's +19.1% suggests higher risk. The company pays no dividend, so returns depend on price appreciation. A minimum holding period of 12 months is recommended to allow the earnings growth story to play out and for analyst coverage to expand.